Cellosaurus LNCaP-PDR2 (CVCL_C0RS)
Cell line name | LNCaP-PDR2 |
---|---|
Synonyms | LNCaP PDR2; LN-PDR2 |
Accession | CVCL_C0RS |
Resource Identification Initiative | To cite this cell line use: LNCaP-PDR2 (RRID:CVCL_C0RS) |
Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance). Omics: Deep quantitative phosphoproteome analysis. Omics: Transcriptome analysis by RNAseq. Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056. |
Sequence variations |
|
Disease | Prostate carcinoma (NCIt: C4863) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0395 (LNCaP) |
Sex of cell | Male |
Age at sampling | 50Y |
Category | Cancer cell line |
Publications | PubMed=29739788; DOI=10.1158/1078-0432.CCR-18-0410; PMCID=PMC6125187 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_C0RS |
Encyclopedic resources | Wikidata; Q112930020 |
Gene expression databases | GEO; GSM2650011
GEO; GSM2650012 GEO; GSM2650013 GEO; GSM2650014 GEO; GSM2650015 GEO; GSM2650016 |
Proteomic databases | PRIDE; PXD006561 |
Entry history | |
Entry creation | 23-Jun-2022 |
Last entry update | 19-Dec-2024 |
Version number | 6 |